NCT06371495

Brief Summary

Strokes is amajor cause of death and disabilities in different countried

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

August 13, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

7 months

First QC Date

April 14, 2024

Last Update Submit

April 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Carotid duplex will be done at the onset and after 1 month and 3 months of the onset.

    measure the carotid thickness through Carotid duplex

    first day and after 3 mounths

Study Arms (2)

Group ABC

GroupA: recieve rosuvastatin 40mg

Drug: rosuvastatin

Group B

Group B :recive rosuvastatin20

Drug: rosuvastatin

Interventions

Stude include three groupsof people GroupA: recieve rosuvastatin 40mg Group B :recive rosuvastatin 20mg Group C: recive placebo 2- Follow up will be done using NIHSS at the onset and modified Rankin scale at the onset and after 1 month and 3 months of the onset. 3- Carotid duplex will be done at the onset and after 1 month and 3 months of the onset.

Also known as: ststins
Group ABCGroup B

Eligibility Criteria

Age20 Years - 99 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

people have acute ischemic stroke

You may qualify if:

  • patients.have acute ischemic stroke within 24 hours of onset. 2.patient not received intravenous thrombolysis or mechanical thrombectomy3.patients with no contraindications or hypersensitivity to statins

You may not qualify if:

  • \. Patient received IV thrombolysis or underwent mechanical thrombectomy 2. patient have acute ischemic stroke with onset of more than 24 hours 3.patients have hypersestivty or contraindication to statin 4:patients refuse to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Gandhi BS, Kanungo MS. Effect of cortisone on monoamine oxidase of the liver of young & old rats. Indian J Biochem Biophys. 1974 Jun;11(2):102-4. No abstract available.

MeSH Terms

Conditions

Stroke

Interventions

Rosuvastatin Calcium

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

SulfonamidesAmidesOrganic ChemicalsFluorobenzenesHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbonsSulfonesSulfur CompoundsPyrimidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

April 14, 2024

First Posted

April 17, 2024

Study Start

August 13, 2024

Primary Completion

February 28, 2025

Study Completion

August 30, 2025

Last Updated

April 17, 2024

Record last verified: 2024-04